From April 12, 2024 to May 13, 2024, the company has repurchased 350,000 shares, representing 2.23% for ¥868.86 million. With this, the company has completed the repurchase of 350,000 shares, representing 2.23% for ¥868.86 million under the buyback announced on April 12, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,250 JPY | +1.35% | +0.94% | +18.11% |
1st Jan change | Capi. | |
---|---|---|
+18.11% | 219M | |
+20.37% | 43.54B | |
+19.44% | 21.78B | |
+17.85% | 15.38B | |
+25.55% | 15.12B | |
+60.99% | 13.36B | |
-0.05% | 6.79B | |
-15.02% | 6.38B | |
-8.87% | 5.73B | |
+8.17% | 5.32B |
- Stock Market
- Equities
- 4577 Stock
- News Daito Pharmaceutical Co.,Ltd.
- Tranche Update on Daito Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on April 12, 2024.